University of Pennsylvania Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The CAR T-cell therapy race
Unlike childhood acute lymphoblastic leukemia (ALL), there are currently no approved CAR T-cell products for the treatment of adult ALL; here, Noelle Frey, MD, from the University of Pennsylvania, Phi... Author: VJOncology Added: 05/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 24, 2018 Category: Cancer & Oncology Source Type: podcasts

Who Should Get PRRT?
Soulen - Who Should Get PRRT Weighing Cumulative Toxicity Key to PRRT Treatment<br /><br />Michael C. Soulen, MD of the University of Pennsylvania answers the question "Who Should Get PRRT?". He summarizes th... Author: AnnualMeetingGI2016 Added: 01/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 19, 2018 Category: Cancer & Oncology Source Type: podcasts

Primary Resection of Tumor in Gut No Survival Difference Between Resected and Non-Resected
Michael C. Soulen, MD of the University of Pennsylvania discusses primary resection of tumor in the gut and how there is evidence that there is no survival difference between resected and non-resected... Author: AnnualMeetingGI2016 Added: 01/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 19, 2018 Category: Cancer & Oncology Source Type: podcasts

Peptide Receptor Radionuclide Therapy US Approval Expected Early 2018
Michael C. Soulen, MD of the University of Pennsylvania discusses that peptide receptor radionuclide therapy US approval expected early 2018 from ASCO GI 2018. Author: AnnualMeetingGI2016 Added: 01/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 19, 2018 Category: Cancer & Oncology Source Type: podcasts

Is PRRT Practice Changing?
Michael C. Soulen, MD of the University of Pennsylvania answers the question "Is PRRT Practice Changing?". He summarizes that cost, approval designation and faculty skill sets will limit pep... Author: AnnualMeetingGI2016 Added: 01/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 19, 2018 Category: Cancer & Oncology Source Type: podcasts

First PET Scan Lung Cancer Scan Nodules Over 8 mm
Daniel A. Pryma, MD of the University of Pennsylvania discusses how first pet scan for lung cancer should occur in nodules over 8 mm. From the 22nd Annual Perspectives in Thoracic Oncology in New York... Author: thoraciconcology Added: 01/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Fluorodeoxyglucose (FDG) PET Still Powerful Tool for Lung Cancer
Daniel A. Pryma, MD of the University of Pennsylvania discusses how fluorodeoxyglucose (fdg) pet scan is still powerful tool for lung cancer. From the 22nd Annual Perspectives in Thoracic Oncology in ... Author: thoraciconcology Added: 01/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Imaging Immunotherapy and Lung Cancer
Daniel A. Pryma, MD of the University of Pennsylvania discusses imaging immunotherapy and lung cancer. From the 22nd Annual Perspectives in Thoracic Oncology in New York <a target='_blank' href='http://imedex.com/perspectives'>http://imedex.com/perspecti...</a>... Author: thoraciconcology Added: 01/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Serious Illness Conversation Guides Helpful in Creating Mutual Goals
Beth Eaby-Sandy, MSN, CRNP of University of Pennsylvania talks about the serious illness conversation guides and how they can be helpful in creating mutual doctor / patient goals from the 22nd Annual ... Author: thoraciconcology Added: 12/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 29, 2017 Category: Cancer & Oncology Source Type: podcasts

Patient Conversations with Loved One Engage With Patient First and Foremost
Beth Eaby-Sandy, MSN, CRNP of University of Pennsylvania patient conversations with loved ones always engage with patient first and foremost from the 22nd Annual Perspectives in Thoracic Oncology in N... Author: thoraciconcology Added: 12/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 29, 2017 Category: Cancer & Oncology Source Type: podcasts

Patient Conversation Management I hope but I worry
Beth Eaby-Sandy, MSN, CRNP of University of Pennsylvania discusses patient conversation management and the "I hope but I worry" phrase from the 22nd Annual Perspectives in Thoracic Oncology in New Yor... Author: thoraciconcology Added: 12/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 29, 2017 Category: Cancer & Oncology Source Type: podcasts

Barriers to Patient Communication Advertising, Clinical Jargon, Hopeful Messaging
Beth Eaby-Sandy, MSN, CRNP of University of Pennsylvania discusses barriers to patient communication advertising, clinical jargon, and encouraging hopeful messages from the 22nd Annual Perspectives in... Author: thoraciconcology Added: 12/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 29, 2017 Category: Cancer & Oncology Source Type: podcasts

Thoracic Oncology in 2018 Finding Better Biomarkers
Joshua Bauml, MD of the University of Pennsylvania discusses thoracic oncology in 2018 finding better biomarkers from the 22nd Annual Perspectives in Thoracic Oncology in New York <a target='_blank' href='http://imedex.com/pe'>http://imedex.com/pe...</a>... Author: thoraciconcology Added: 12/28/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 28, 2017 Category: Cancer & Oncology Source Type: podcasts

Osimertinib Versus Erlotinib or Gefitinib in The FLAURA Trial
Joshua Bauml, MD of the University of Pennsylvania discusses Osimertinib v Erlotinib or Gefitinib in the FLAURA Trial from the 22nd Annual Perspectives in Thoracic Oncology in New York <a target='_blank' href='http://imedex.c'>http://imedex.c...</a>... Author: thoraciconcology Added: 12/28/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 28, 2017 Category: Cancer & Oncology Source Type: podcasts

Next Generation Sequencing Assays Will Allow More Targeting in Specific Patients
Joshua Bauml, MD of the University of Pennsylvania discusses the next generation sequencing assays which will allow more targeting in specific patients from the 22nd Annual Perspectives in Thoracic On... Author: thoraciconcology Added: 12/28/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 28, 2017 Category: Cancer & Oncology Source Type: podcasts